(Q35125968)

6 August 2017

title

Quality-of-care indicators for early-stage prostate cancer (English)

1 reference

6 August 2017

Quality-of-Care Indicators for Early-Stage Prostate Cancer (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

1 January 2024

0 references

1 reference

health care quality indicators

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743145

1 January 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

1 January 2024

5

Mark S Litwin

1 reference

6 August 2017

Michael Steinberg

2

1 reference

6 August 2017

Jennifer Malin

3

1 reference

6 August 2017

John Adams

4

1 reference

6 August 2017

Benjamin A. Spencer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743145

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743145

full work available at URL

1 January 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.05.157

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Journal of Clinical Oncology

1 January 2024

published in

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

10

1 reference

6 August 2017

page(s)

1928-1936

1 reference

Hospital cost containment in the 1980s. Hard lessons learned and prospects for the 1990s

6 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Defining and measuring quality of care: a perspective from US researchers

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Physician ratings of appropriate indications for six medical and surgical procedures

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Relation between surgeons' practice volumes and geographic variation in the rate of carotid endarterectomy

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals.

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Hospital volume and surgical mortality in the United States.

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Variations in morbidity after radical prostatectomy

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?.

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer?

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better?

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

An enhanced prognostic system for clinically localized carcinoma of the prostate

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatment

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 January 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomy

1 January 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The impact of co-morbidity on life expectancy among men with localized prostate cancer

1 January 2024

30

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study

1 January 2024

33

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

1 January 2024

35

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

1 January 2024

36

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Quality-of-life outcomes in men treated for localized prostate cancer.

1 January 2024

37

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

1 January 2024

38

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The role of provider continuity in preventing hospitalizations

1 January 2024

40

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The importance of continuity of care in the likelihood of future hospitalization: is site of care equivalent to a primary clinician?

1 January 2024

41

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer

1 January 2024

43

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity

1 January 2024

44

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 January 2024

45

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

1 January 2024

46

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Analysis of prostate and seminal vesicle motion: implications for treatment planning

1 January 2024

47

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization

1 January 2024

48

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy

1 January 2024

49

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The use of quality indicators for assessing radical prostatectomy specimens

1 January 2024

52

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

PSAdynia and other PSA-related syndromes: a new epidemic--a case history and taxonomy

1 January 2024

53

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: do we know how to use it?

1 January 2024

54

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

1 January 2024

55

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

The management of clinically localized prostate cancer: guidelines from the American Urological Association

1 January 2024

56

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy

1 January 2024

57

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.05.157

1 January 2024

Identifiers

1 reference

6 August 2017

1 reference